CEO. Professor in Experimental Endocrinology and Director of The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Stockholm, Sweden. Guest Professor at the University of Miami, Miller School of Medicine, USA, and at Postech, Pohang, Korea. Distinguished Professor at the University of Rome Tor Vergata, Italy since October 2016. Activities in professional organizations: ...

Acting COO.  James has 16 years industry experience, including 12 years with AstraZeneca.  While there, he held a number of commercial, R&D and Bus Dev roles, including VP Global Marketing for CV/GI Therapy Area, Global Product VP for Crestor and most recently VP Evaluation for the CV/Metabolism Therapy Area.  Prior to this he was a ...

Member of the Board between June 2014 and June 2017. Chairman and CEO for Olsson Solutions AB. Chairman of the Board for Athera Biotechnologies. Board member of IRLab Therapeutics AB and Cereno Scientific AB. Senior roles in the Astra Group/AstraZeneca since 1989, most recently as Leader/Chairman of the Global Cardiovascular & Gastrointestinal Therapy Area during ...

CFO in Biocrine since 2007. B.Sc. in Biology from Stockholm University. More than 30 years of experience in business management, mainly in the IT, Life Science and biotech industry.